Employee's wages in arrears, Indofarma to divest assets
03 Sep 2024 09:07
PT Indofarma Tbk (INAF), a state-owned medicine and medical device manufacturer, is said to sell off its remaining assets to pay arrears to its own employees.
Indofarma still on loss streak until H1 2024
02 Aug 2024 13:01
PT Indofarma Tbk (INAF), a state-owned pharmaceutical company owned through PT Bio Farma (Persero), booked a loss of IDR 101.94 billion in the first half (H1) of 2024.
Official, shareholders approve INAF’s 50%-of-assets guarantee
16 Jan 2024 10:27
The shareholders of PT Indofarma Tbk (INAF) has agreed upon the guarantee of over 50% of net assets of the company as a collateral for the company’s obligation.
INAF’s shareholders greenlit shareholder loan from Bio Farma
31 May 2023 17:29
The proposal of PT Indofarma (Persero) Tbk (INAF) to request for a shareholder loan worth IDR 157 billion had been approved by independent shareholders during today’s (31/5) Annual General Shareholders Meeting.
Indofarma secures shareholder loan of IDR 157 billion
30 May 2023 08:11
PT Indofarma (Persero) Tbk (INAF) obtains a loan from PT Bio Farma (Persero), its controlling shareholder, worth IDR 157 billion for restructuring.
Bio Farma ready to provide IDR 157 billion loan for Indofarma's restructuring
19 Apr 2023 05:40
PT Bio Farma (Persero), the parent of a pharmaceutical holding company owned by the Government of Indonesia, will distribute a loan facility worth IDR 157 billion to support the restructuring plan of PT Indofarma Tbk (INAF).
Revenue down 60.56%, Indofarma's loss worsened
03 Apr 2023 06:01
The revenue of PT Indofarma Tbk (INAF), a pharmaceutical company, was seen declining 60.56% year-on-year (yoy).
